{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:55:45Z","timestamp":1790740545187,"version":"4.1.0"},"reference-count":116,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is the first cause of chronic liver disease worldwide; it ranges from simple steatosis to steatohepatitis (NASH) and, potentially, cirrhosis and hepatocarcinoma. NAFLD is also an independent risk factor for type 2 diabetes, cardiovascular diseases, and mortality. As it is largely associated with insulin resistance and related disorders, NAFLD has been recently re-named as Metabolic dysfunction-Associated Fatty Liver Disease (MAFLD). At present, there are no approved pharmacological treatments for this condition. Vitamin D is a molecule with extensive anti-fibrotic, anti-inflammatory, and insulin-sensitizing properties, which have been proven also in hepatic cells and is involved in immune-metabolic pathways within the gut\u2013adipose tissue\u2013liver axis. Epidemiological data support a relationship hypovitaminosis D and the presence of NAFLD and steatohepatitis (NASH); however, results from vitamin D supplementation trials on liver outcomes are controversial. This narrative review provides an overview of the latest evidence on pathophysiological pathways connecting vitamin D to NAFLD, with emphasis on the effects of vitamin D treatment in MAFLD by a nonsystematic literature review of PubMed published clinical trials. This article conforms to the Scale for Assessment of Narrative Review Articles (SANRA) guidelines. Evidence so far available supports the hypothesis of potential benefits of vitamin D supplementation in selected populations of NAFLD patients, as those with shorter disease duration and mild to moderate liver damage.<\/jats:p>","DOI":"10.3390\/nu12113302","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T11:43:06Z","timestamp":1603885386000},"page":"3302","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":175,"title":["Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0530-8568","authenticated-orcid":false,"given":"Ilaria","family":"Barchetta","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University, Viale Regina Elena 321, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Agata","family":"Cimini","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University, Viale Regina Elena 321, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6630-8049","authenticated-orcid":false,"given":"Maria Gisella","family":"Cavallo","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University, Viale Regina Elena 321, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2016). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Paik, J.M., Golabi, P., Younossi, Y., Mishra, A., and Younossi, Z.M. (2020). Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease. Hepatology.","DOI":"10.1002\/hep.31173"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Alexander, M., Loomis, A.K., Fairburn-Beech, J., Van Der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., and Rijnbeek, P. (2018). Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med., 16.","DOI":"10.1186\/s12916-018-1103-x"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver Int."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Charoenngam, N., and Holick, M.F. (2020). Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients, 12.","DOI":"10.3390\/nu12072097"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Szymczak-Pajor, I., Drzewoski, J., and \u015aliwi\u0144ska, A. (2020). The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186644"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Benetti, E., Mastrocola, R., Chiazza, F., Nigro, D., D\u2019Antona, G., Bordano, V., Fantozzi, R., Aragno, M., Collino, M., and Minetto, M.A. (2018). Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0189707"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2003-031005","article-title":"Adipocytokines and insulin resistance","volume":"89","author":"Pittas","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1210\/en.2002-220449","article-title":"1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: Implication of the antiapoptotic protein A20","volume":"143","author":"Riachy","year":"2002","journal-title":"Endocrinology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Cimini, F.A., and Cavallo, M.G. (2017). Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future. Nutrients, 9.","DOI":"10.3390\/nu9091015"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/gut.2010.234666","article-title":"Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats","volume":"60","author":"Abramovitch","year":"2011","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Angelico, F., Del Ben, M., Baroni, M.G., Pozzilli, P., Morini, S., and Cavallo, M.G. (2011). Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-85"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dawson-Hughes, B., Staten, M.A., Knowler, W.C., Nelson, J., Vickery, E.M., Leblanc, E.S., Neff, L.M., Park, J., and Pittas, A.G. (2020). D2d Research Group Investigators. Intratrial Exposure to Vitamin D and New-Onset Diabetes among Adults with Prediabetes: A Secondary Analysis from the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care, dc201765.","DOI":"10.2337\/dc20-1765"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Barchetta, I., De Bernardinis, M., Capoccia, D., Baroni, M.G., Fontana, M., Fraioli, A., Morini, S., Leonetti, F., and Cavallo, M.G. (2013). Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068689"},{"key":"ref_21","first-page":"755","article-title":"Could vitamin d supplementation benefit patients with chronic liver disease?","volume":"8","author":"Barchetta","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.3748\/wjg.v23.i19.3407","article-title":"Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease","volume":"23","author":"Cimini","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4291\/wjgp.v10.i2.11","article-title":"Overview of studies of the vitamin D\/vitamin D receptor system in the development of non-alcoholic fatty liver disease","volume":"10","author":"Cimini","year":"2019","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3748\/wjg.v21.i6.1718","article-title":"Vitamin D: A new player in non-alcoholic fatty liver disease?","volume":"21","author":"Eliades","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.clinre.2019.10.007","article-title":"Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model","volume":"44","author":"Ma","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1507\/endocrj.EJ16-0542","article-title":"Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model","volume":"64","author":"Zhu","year":"2017","journal-title":"Endocr. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hep.24737","article-title":"Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation","volume":"55","author":"Roth","year":"2012","journal-title":"Hepatology"},{"key":"ref_29","first-page":"410","article-title":"Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients","volume":"44","author":"Wu","year":"2014","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1074\/jbc.RA119.011487","article-title":"Vitamin D receptor targets hepatocyte nuclear factor 4\u03b1 and mediates protective effects of vitamin D in nonalcoholic fatty liver disease","volume":"295","author":"Zhang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.25930","article-title":"Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: Relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus","volume":"56","author":"Barchetta","year":"2012","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.30937","article-title":"Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice","volume":"71","author":"Dong","year":"2020","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/gutjnl-2014-307024","article-title":"Vitamin D counteracts fibrogenic TGF-beta signaling in human hepatic stellate cells both receptor-dependently and independently","volume":"64","author":"Beilfuss","year":"2015","journal-title":"Gut"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","article-title":"A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response","volume":"153","author":"Ding","year":"2013","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"G112","DOI":"10.1152\/ajpgi.00132.2013","article-title":"Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis","volume":"308","author":"Abramovitch","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/liv.14554","article-title":"Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity","volume":"40","author":"Barchetta","year":"2020","journal-title":"Liver Int."},{"key":"ref_37","unstructured":"Tilg, H., Adolph, T.E., and Moschen, A.R. (2020). Multiple Parallel Hits Hypothesis in NAFLD\u2014Revisited After a Decade. Hepatology."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Cimini, F.A., Barchetta, I., Ciccarelli, G., Leonetti, F., Silecchia, G., Chiappetta, C., Di Cristofano, C., Capoccia, D., Bertoccini, L., and Ceccarelli, V. (2020). Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease. Diabetes Metab. Res. Rev., e3358.","DOI":"10.1002\/dmrr.3358"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.gastro.2015.05.044","article-title":"Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease","volume":"149","author":"Korf","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1210\/jc.2017-02751","article-title":"Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes","volume":"103","author":"Barchetta","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/CEG.S262879","article-title":"Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats","volume":"13","author":"Longo","year":"2020","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/dmrr.873","article-title":"1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells","volume":"24","author":"Zhou","year":"2004","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Parker, L., Levinger, I., Mousa, A., Howlett, K., and de Courten, B. (2016). Plasma 25-Hydroxyvitamin D Is Related to Protein Signaling Involved in Glucose Homeostasis in a Tissue-Specific Manner. Nutrients, 8.","DOI":"10.3390\/nu8100631"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biopha.2016.11.116","article-title":"Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylation in diabetic rats","volume":"85","author":"Elseweidy","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/met.2012.0068","article-title":"Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes","volume":"11","author":"Alkharfy","year":"2013","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_46","first-page":"e74255","article-title":"Vitamin D Increases Glucose Stimulated Insulin Secretion from Insulin Producing Beta Cells (INS1E)","volume":"17","author":"Bornstedt","year":"2019","journal-title":"Int. J. Endocrinol. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s40618-019-01052-3","article-title":"Sick fat: The good and the bad of old and new circulating markers of adipose tissue inflammation","volume":"42","author":"Barchetta","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1042\/CS20160348","article-title":"Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes","volume":"130","author":"Barchetta","year":"2016","journal-title":"Clin. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1210\/js.2017-00108","article-title":"WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes","volume":"1","author":"Barchetta","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00592-017-1039-1","article-title":"Circulating IL-8 levels are increased in patients with type 2 diabetes and associated with worse inflammatory and cardiometabolic profile","volume":"54","author":"Cimini","year":"2017","journal-title":"Acta Diabetol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","article-title":"From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options","volume":"1","author":"Gastaldelli","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1139\/cjpp-2019-0340","article-title":"Vitamin D alleviates oxidative stress in adipose tissue and mesenteric vessels from obese patients with subclinical inflammation","volume":"98","author":"Ionica","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s10753-017-0610-9","article-title":"Adipose Tissue Inflammation and Oxidative Stress: The Ameliorative Effects of Vitamin D","volume":"40","author":"Farhangi","year":"2017","journal-title":"Inflammation"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Marziou, A., Philouze, C., Couturier, C., Astier, J., Obert, P., Landrier, J.-F., and Riva, C. (2020). Vitamin D Supplementation Improves Adipose Tissue Inflammation and Reduces Hepatic Steatosis in Obese C57BL\/6J Mice. Nutrients, 12.","DOI":"10.3390\/nu12020342"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Su, Y.-B., Li, T.-H., Huang, C.-C., Tsai, H.-C., Huang, S., Hsieh, Y.-C., Yang, Y.-Y., Huang, Y.-H., Hou, M.-C., and Lin, H.-C. (2018). Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal\/adipose tissue alteration in a diet-induced steatohepatitis rat model. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194867"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"172761","DOI":"10.1016\/j.ejphar.2019.172761","article-title":"VDR regulates energy metabolism by modulating remodeling in adipose tissue","volume":"865","author":"Xu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Jonas, M., Kurylowicz, A., Bartoszewicz, Z., Lisik, W., Jonas, M., Ko\u017aniewski, K., and Puzianowska-Kuznicka, M. (2019). Vitamin D Receptor Gene Expression in Adipose Tissue of Obese Individuals is Regulated by miRNA and Correlates with the Pro-Inflammatory Cytokine Level. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215272"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Chiappetta, C., Ceccarelli, V., Cimini, F.A., Bertoccini, L., Gaggini, M., Di Cristofano, C., Silecchia, G., Lenzi, A., and Leonetti, F. (2020). Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197197"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?","volume":"158","author":"Warmbrunn","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3389\/fphys.2018.01813","article-title":"Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease","volume":"9","author":"Porras","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"105663","DOI":"10.1016\/j.jsbmb.2020.105663","article-title":"Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation","volume":"200","author":"Fakhoury","year":"2020","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2012.04.001","article-title":"Where is the vitamin D receptor?","volume":"523","author":"Wang","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2017.04.010","article-title":"Vitamin D signaling in intestinal innate immunity and homeostasis","volume":"453","author":"Dimitrov","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"G542","DOI":"10.1152\/ajpgi.00286.2019","article-title":"Vitamin D signaling maintains intestinal innate immunity and gut microbiota: Potential intervention for metabolic syndrome and NAFLD","volume":"318","author":"Fakhoury","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s10620-015-3710-0","article-title":"Does Vitamin D Protect the Gut Mucosal Barrier? Mechanistic Insights from Experimental Colitis","volume":"60","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MCO.0000000000000516","article-title":"Dietary vitamin D, vitamin D receptor, and microbiome","volume":"21","author":"Sun","year":"2018","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"106112","DOI":"10.1016\/j.intimp.2019.106112","article-title":"Vitamin D and microbiota: Two sides of the same coin in the immunomodulatory aspects","volume":"79","author":"Malaguarnera","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"38751","DOI":"10.1074\/jbc.C110.185777","article-title":"Vitamin D suppresses Th17 cytokine production by inducing C\/EBP homologous protein [CHOP) expression","volume":"285","author":"Chang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e12461","DOI":"10.1111\/cpr.12461","article-title":"1,25(OH) (2) D(3) inhibited Th17 cells differentiation via regulating the NF-\u03baB activity and expression of IL-17","volume":"51","author":"Sun","year":"2018","journal-title":"Cell Prolif."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/mi.2015.49","article-title":"Regulatory immune cells in regulation of intestinal inflammatory response to microbiota","volume":"8","author":"Sun","year":"2015","journal-title":"Mucosal. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08830185.2013.843983","article-title":"The Th17 cell population and the immune homeostasis of the gastrointestinal tract","volume":"32","author":"Rossi","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fimmu.2019.00426","article-title":"Microbiome dependent regulation of T(regs) and Th17 cells in mucosa","volume":"10","author":"Pandiyan","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature25437","article-title":"Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism","volume":"554","author":"Mao","year":"2018","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4735040","DOI":"10.1155\/2019\/4735040","article-title":"Gut Microbiota Modulation on Intestinal Mucosal Adaptive Immunity","volume":"2019","author":"Wang","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"G208","DOI":"10.1152\/ajpgi.00398.2007","article-title":"Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier","volume":"294","author":"Kong","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.toxlet.2015.06.006","article-title":"Protective effect of 1,25-dihydroxyvitamin D3 on ethanol-induced intestinal barrier injury both in vitro and in vivo","volume":"237","author":"Chen","year":"2015","journal-title":"Toxicol. Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10753-014-0041-9","article-title":"Protective effect of 1,25-dihydroxyvitamin d3 on lipopolysaccharide-induced intestinal epithelial tight junction injury in caco-2 cell monolayers","volume":"38","author":"Chen","year":"2015","journal-title":"Inflammation"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2015.03.125","article-title":"1,25-Dihydroxyvitamin D3 preserves intestinal epithelial barrier function from TNF-\u03b1 induced injury via suppression of NF-kB p65 mediated MLCK-P-MLC signalling pathway","volume":"460","author":"Chen","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1210\/en.2017-00748","article-title":"Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis","volume":"159","author":"He","year":"2018","journal-title":"Endocrinology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fphys.2016.00498","article-title":"Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models","volume":"7","author":"Su","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1248\/bpb.b20-00432","article-title":"A Lipid-Based Nanocarrier Containing Active Vitamin D3 Ameliorates NASH in Mice via Direct and Intestine-Mediated Effects on Liver Inflammation","volume":"43","author":"Mu","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"G1299","DOI":"10.1152\/ajpgi.00320.2012","article-title":"Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses","volume":"303","author":"Ryz","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MIB.0000000000000282","article-title":"Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury","volume":"21","author":"Assa","year":"2015","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/en.2010-0089","article-title":"Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis","volume":"151","author":"Lagishetty","year":"2010","journal-title":"Endocrinology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.clinthera.2015.04.004","article-title":"Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiota","volume":"37","author":"Jin","year":"2015","journal-title":"Clin. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/mi.2014.94","article-title":"Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells","volume":"8","author":"Chen","year":"2015","journal-title":"Mucosal. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2353\/ajpath.2010.090998","article-title":"Vitamin D receptor negatively regulates bacterial-stimulated NF-kappa B activity in intestine","volume":"177","author":"Wu","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.bbagen.2012.09.020","article-title":"Implication of intestinal VDR deficiency in inflammatory bowel disease","volume":"1830","author":"Kim","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.00105.2015","article-title":"Vitamin D receptor pathway is required for probiotic protection in colitis","volume":"309","author":"Wu","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/ng.3695","article-title":"Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota","volume":"48","author":"Wang","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/hep.23724","article-title":"Low levels of 25-hydroxyvitamin D (3) in children with biopsy-proven nonalcoholic fatty liver disease","volume":"51","author":"Manco","year":"2010","journal-title":"Hepatology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-13-0609","article-title":"Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease","volume":"170","author":"Nobili","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.numecd.2006.04.002","article-title":"Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease","volume":"17","author":"Targher","year":"2007","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Keane, J.T., Elangovan, H., Stokes, R.A., and Gunton, J.E. (2018). Vitamin D and the liver-correlation or cause?. Nutrients, 10.","DOI":"10.3390\/nu10040496"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4254\/wjh.v10.i1.142","article-title":"Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data","volume":"10","author":"Saberi","year":"2018","journal-title":"World J. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.dld.2017.02.003","article-title":"Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"49","author":"Jaruvongvanich","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"S975","DOI":"10.1016\/j.dsx.2017.07.025","article-title":"The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Tabrizi","year":"2017","journal-title":"Diabetes Metab Syndr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1039\/D0FO01095B","article-title":"Vitamin D and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials","volume":"11","author":"Guo","year":"2020","journal-title":"Food Funct."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gutjnl-2015-310417","article-title":"High-dose vitamin D supplementation and liver histology in NASH","volume":"65","author":"Kitson","year":"2016","journal-title":"Gut"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jgh3.12010","article-title":"Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial","volume":"1","author":"Sakpal","year":"2017","journal-title":"JGH Open"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.clnu.2016.09.020","article-title":"Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial","volume":"36","author":"Amiri","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_103","first-page":"631","article-title":"Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial","volume":"19","author":"Amiri","year":"2016","journal-title":"Arch. Iran. Med."},{"key":"ref_104","first-page":"969","article-title":"Effect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver","volume":"5","author":"Foroughi","year":"2014","journal-title":"Int. J. Prev. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-014-0336-5","article-title":"Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial","volume":"47","author":"Sharifi","year":"2014","journal-title":"Endocrine"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Barchetta, I., Del Ben, M., Angelico, F., Di Martino, M., Fraioli, A., La Torre, G., Saulle, R., Perri, L., Morini, S., and Tiberti, C. (2016). No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. BMC Med., 14.","DOI":"10.1186\/s12916-016-0638-y"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1080\/00365521.2018.1501091","article-title":"Treatment of non-alcoholic steatohepatitis patients with vitamin D: A double-blinded, randomized, placebo-controlled pilot study","volume":"53","author":"Geier","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.dsx.2018.03.006","article-title":"Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial","volume":"12","author":"Dabbaghmanesh","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jsbmb.2017.09.009","article-title":"The relationship between 25-hydroxyvitamin D concentration and liver enzymes in overweight or obese adults: Cross-sectional and interventional outcomes","volume":"177","author":"Naderpoora","year":"2018","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Javed, Z., Papageorgiou, M., Deshmukh, H., Kilpatrick, E.S., Mann, V., Corless, L., Abouda, G., Rigby, A.S., Atkin, S.L., and Sathyapalan, T. (2019). A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients, 11.","DOI":"10.3390\/nu11010188"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1111\/j.1464-5491.2012.03672.x","article-title":"Effect of vitamin D supplementation on glycaemic control and insulin resistance: A systematic review and meta-analysis","volume":"29","author":"George","year":"2012","journal-title":"Diabet. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/dme.12893","article-title":"Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: A systematic review and meta-analysis","volume":"33","author":"Poolsup","year":"2016","journal-title":"Diabet. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11892-020-01349-1","article-title":"Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease","volume":"20","author":"Budd","year":"2020","journal-title":"Curr. Diabetes Rep."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Della Corte, C., Carpino, G., De Vito, R., De Stefanis, C., Alisi, A., Cianfarani, S., Overi, D., Mosca, A., Stronati, L., and Cucchiara, S. (2016). Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168216"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/oby.22964","article-title":"A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD","volume":"28","author":"Moore","year":"2020","journal-title":"Obesity"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11657-019-0589-y","article-title":"Cost-benefit analysis of calcium and vitamin D supplements","volume":"14","author":"Weaver","year":"2019","journal-title":"Arch. Osteoporos."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/11\/3302\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:29:53Z","timestamp":1760178593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/11\/3302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":116,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["nu12113302"],"URL":"https:\/\/doi.org\/10.3390\/nu12113302","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]}}}